Multifactorial Intervention on Diabetes (MIDiab Study)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 6300 participants.
Also called NCT03430284
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 6,300 participants
- Sponsor
- Registry
-
NCT03430284
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03430284. Randomized; no masking; primary purpose treatment. Start 2018-04-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multifactorial Intervention on Diabetes (MIDiab Study)
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Behavioral)
- Lifestyle therapy
- Intervention (Drug)
- Pharmacotherapy
- Intervention (Other)
- Monitoring and management
- Intervention (Other)
- General treatment
- Lead sponsor
- Shandong Provincial Hospital
- Collaborator
- The Affiliated Hospital of Qingdao University
- Collaborator
- The First Hospital of Jilin University
- Collaborator
- The First People's Hospital of Yinchuan
- Collaborator
- Beijing Hospital, National Center of Gerontology
- Collaborator
- The First Affiliated Hospital of Air Force Medical University
- Collaborator
- Inner Mongolia People's Hospital
- Collaborator
- The Affiliated Hospital of Inner Mongolia Medical University
- Collaborator
- Fujian Medical University Union Hospital
- Collaborator
- The Fourth Affiliated Hospital of Harbin Medical University
- Collaborator
- Yantai Yuhuangding Hospital
Record details
- Record id
cardio:ct-nct03430284- Content hash
7baf42ba490e796e56f4e1925aa7f6e58122ae335b01dc67f1c8656a5f2b3683